Sheng-Shun Yang

4PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Disease surveillanceRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 07, 2025
Immune-mediated adverse events in the randomized phase 3 TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer.

Lorenzo Antonuzzo, Hidenori Takahashi, Joon Oh Park

|May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort Study.

Shih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li

|Aug 05, 2022
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study.

Chen-Hua Liu, Hsin-Yun Sun, Cheng-Yuan Peng

|Apr 02, 2019
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.

Chen-Hua Liu, Yu-Lueng Shih, Sheng-Shun Yang

Pageof 1

Frequent Collaborators

2 joint publications

Chen-Hua Liu

2 joint publications

Chun-Jen Liu

2 joint publications

Jia-Horng Kao

1 joint publications

Hsin-Yun Sun